Ads
related to: lupus alternative therapies that work- See A Treatment Option
Learn More About A Treatment Option
For Lupus & Discover How It Works.
- Learn About Lupus
Discover Symptoms, Triggers, & How
Lupus Affects The Immune System.
- See Possible Side Effects
See Possible Side Effects For A
Lupus Nephritis Treatment Option.
- Causes Of Lupus Nephritis
Visit To Learn More About The
Causes Of Lupus Nephritis Today.
- Lupus Tools & Resources
Find Tools, Videos And Resources
To Help You Understand Lupus.
- Doctor Discussion Tips
Learn About Tips To Help You Talk
To Your Doctor At Your Next Visit.
- See A Treatment Option
Search results
Results From The WOW.Com Content Network
Anifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus. [5] [7] It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β. [medical citation needed]
Voclosporin, sold under the brand name Lupkynis, is a calcineurin inhibitor used as an immunosuppressant medication for the treatment of lupus nephritis. [2] [4] It is an analog of ciclosporin that has enhanced action against calcineurin and greater metabolic stability.
There is no cure for SLE, [1] but there are experimental and symptomatic treatments. [6] Treatments may include NSAIDs, corticosteroids, immunosuppressants, hydroxychloroquine, and methotrexate. [1] Although corticosteroids are rapidly effective, long-term use results in side effects. [7] Alternative medicine has not been shown to affect the ...
The Lupus Research Alliance (LRA) is an American voluntary health organization based in New York City whose mission is to find better treatments and ultimately prevent and cure systemic lupus erythematosus (SLE or lupus), a debilitating autoimmune disease, through supporting medical research. The organization was born from the merger of three ...
Further work addressing maintenance therapy demonstrated mycophenolate superior to cyclophosphamide, again in terms of response and side-effects. [12] [23] Walsh proposed that mycophenolate should be considered as a first-line induction therapy for treatment of lupus nephritis in people without kidney dysfunction. [24]
Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. [8] Sales rose to $31.2 million in the first quarter of 2012. [37] The total cost for the first year of treatment with belimumab is $28,000. [38]
Ads
related to: lupus alternative therapies that work